Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2015 16:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the Stifel 2015 Healthcare Conference

SAN DIEGO, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
November 05, 2015 16:01 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Provides Corporate Update and Third Quarter 2015 Financial Results

Company Continues to Advance Clinical Pipeline Vitaros Quarterly Unit Sales Increased 146% in Europe Conference Call / Webcast Today, Thursday, November 5, 2015 at 5:00 p.m. ET SAN DIEGO, Nov....
November 02, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Corporate Update and Third Quarter 2015 Financial Results Conference Call

SAN DIEGO, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the...
October 28, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Completes Enrollment in Phase 2b Clinical Trial for Fispemifene in Men with Symptomatic Secondary Hypogonadism

SAN DIEGO, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced...
October 01, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences and Ferring Pharmaceuticals Sign Exclusive Distribution Agreement to Market Topical Erectile Dysfunction Cream Vitaros(TM) in Latin American Countries

SAN DIEGO, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it...
September 17, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon

SAN DIEGO, Sept. 17, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced...
September 10, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Enters Into License Agreement With Allergan for the U.S. Rights to Vitaros(TM)

SAN DIEGO, Sept. 10, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it...
September 02, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

SAN DIEGO, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
September 01, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Italy by Bracco SpA

To Be Commercialized in Italy as Vitaros® SAN DIEGO, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative...
August 19, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces it is Seeking a Global Partner for Femprox, a Novel Treatment for Female Sexual Dysfunction

SAN DIEGO, Calif., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that it re-affirms its intent to...